Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantinos A Demopoulos

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Drug Design, Development and Therapy|December 21, 2016
Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro studyMarilita M Moschos, Eirini Nitoda, Irini P Chatziralli, et al.
Journal of Inorganic Biochemistry|March 18, 2014
Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factorMichael Kaplanis, George Stamatakis, Vasiliki D Papakonstantinou, et al.
Seminars in Ophthalmology|August 14, 2015
In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its MetabolismMarilita M Moschos, Irini P Chatziralli, George Stamatakis, et al.
Journal of Inflammation (London, England)|July 9, 2011
In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombinAlexandros B Tsoupras, Maria Chini, Nickolaos Tsogas, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(<i>η</i><sup>5</sup>-C<sub>5</sub>R<sub>5</sub>)Co{P(OEt)<sub>2</sub>O}<sub>3</sub>]<sup>-</sup>, (R = H, Me; Et = -C<sub>2</sub>H<sub>5</sub>) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and ThrombinAlexandros Kalampalidis, Artemis Damati, Demetrios Matthopoulos, et al.
Lipids in Health and Disease|July 10, 2012
Platelet activating factor levels and metabolism in Tangier disease: a case studyVana Kolovou, Vasiliki D Papakonstantinou, George Stamatakis, et al.
Frontiers in Bioscience (Landmark Edition)|October 30, 2024
Re-Assessing the Role of Platelet Activating Factor and Its Inflammatory Signaling and Inhibitors in Cancer and Anti-Cancer StrategiesAlexandros Tsoupras, Theodora Adamantidi, Marios Argyrios Finos, et al.
Life Sciences|July 25, 2006
Isolation and identification of hydroxyl-platelet-activating factor from natural sourcesAlexandros B Tsoupras, Smaragdi Antonopoulou, George Baltas, et al.
Cytokine|May 16, 2013
Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymesIoanna C Vlachogianni, Tzortzis Nomikos, Elizabeth Fragopoulou, et al.
Journal of Agricultural and Food Chemistry|November 3, 2009
Detection and isolation of antiatherogenic and antioxidant substances present in olive mill wastes by a novel filtration systemGeorge Stamatakis, Nektaria Tsantila, Martina Samiotaki, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Drug Design, Development and Therapy|December 21, 2016
Impact of prostaglandin glaucoma drops on platelet-activating factor action: an in vitro studyMarilita M Moschos, Eirini Nitoda, Irini P Chatziralli, et al.
Journal of Inorganic Biochemistry|March 18, 2014
Re(I) tricarbonyl complex of 1,10-phenanthroline-5,6-dione: DNA binding, cytotoxicity, anti-inflammatory and anti-coagulant effects towards platelet activating factorMichael Kaplanis, George Stamatakis, Vasiliki D Papakonstantinou, et al.
Seminars in Ophthalmology|August 14, 2015
In Vitro Effects of Anti-Glaucomatous Eye Drops on Platelet-Activating Factor and its MetabolismMarilita M Moschos, Irini P Chatziralli, George Stamatakis, et al.
Journal of Inflammation (London, England)|July 9, 2011
In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombinAlexandros B Tsoupras, Maria Chini, Nickolaos Tsogas, et al.
Molecules (Basel, Switzerland)|February 25, 2023
Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(<i>η</i><sup>5</sup>-C<sub>5</sub>R<sub>5</sub>)Co{P(OEt)<sub>2</sub>O}<sub>3</sub>]<sup>-</sup>, (R = H, Me; Et = -C<sub>2</sub>H<sub>5</sub>) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and ThrombinAlexandros Kalampalidis, Artemis Damati, Demetrios Matthopoulos, et al.
Lipids in Health and Disease|July 10, 2012
Platelet activating factor levels and metabolism in Tangier disease: a case studyVana Kolovou, Vasiliki D Papakonstantinou, George Stamatakis, et al.
Frontiers in Bioscience (Landmark Edition)|October 30, 2024
Re-Assessing the Role of Platelet Activating Factor and Its Inflammatory Signaling and Inhibitors in Cancer and Anti-Cancer StrategiesAlexandros Tsoupras, Theodora Adamantidi, Marios Argyrios Finos, et al.
Life Sciences|July 25, 2006
Isolation and identification of hydroxyl-platelet-activating factor from natural sourcesAlexandros B Tsoupras, Smaragdi Antonopoulou, George Baltas, et al.
Cytokine|May 16, 2013
Interleukin-1beta stimulates platelet-activating factor production in U-937 cells modulating both its biosynthetic and catabolic enzymesIoanna C Vlachogianni, Tzortzis Nomikos, Elizabeth Fragopoulou, et al.
Journal of Agricultural and Food Chemistry|November 3, 2009
Detection and isolation of antiatherogenic and antioxidant substances present in olive mill wastes by a novel filtration systemGeorge Stamatakis, Nektaria Tsantila, Martina Samiotaki, et al.
Pageof 6